A comparative pharmacokinetic-pharmacodynamic study of the electrocardiographic effects of epinastine and terfenadine in rats

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 4, 1997, Pages 458-462

  Ohtani, Hisakazu ^a   Kotaki, Hajime ^a   Sawada, Yasufumi ^b   Iga, Tatsuji ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CHLORALOSE; EPINASTINE; TERFENADINE; URETHAN;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROCARDIOGRAPHY; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACODYNAMICS; PR INTERVAL; QT INTERVAL; RAT;

EID: 0030965303     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06824.x     Document Type: Article

References (15)

1. Bazett, H. C. (1920) An analysis of the time-relations of electrocardiograms. Heart 7: 353-370
2. Boehringer Ingelheim (1994) Interview form of Alesion, pp 23-25
3. Davies, A. J., Harindra, V., McEwan, A., Ghose, R. R. (1989) Cardiotoxic effect with convulsions in terfenadine overdose. Br. Med. J. 298: 325
4. Faber, T. S., Zehender, M., Just, H. (1994) Drug-induced torsade de pointes. Drug Safety 11: 463-476
5. Garteiz, D. A., Hook, R. H., Walker, B. J., Okerholm, R. A. (1982) Pharmacokinetics and biotransformation studies of terfenadine in man. Arzneim. Forsch. 32: 1185-1190
6. Keren, A., Tzivoni, D., Gavish, D., Levi, J., Gottlieb, S., Benhorin, J., Stern, S. (1981) Etiology, warning signs and therapy of torsade de pointes. Circulation 64: 1167-1174
7. McConnell, T. J., Stanners, A. J. (1991) Torsades de Pointes complicating treatment with terfenadine. Br. Med. J. 302: 1469
8. Monahan, B. P., Ferguson, C. L., Killeavy, E. S., Lloyd, B. K., Troy, J., Cantilena Jr, R. (1990) Torsades de Pointes occurring in association with terfenadine use. J. Am. Med. Assoc. 264: 2788-2790
9. Ohara, N., Takizawa, M., Yokota, S., Katsumura, H., Konishi, C., Ishiguro, Y., Shukunobe, K., Kitagawa, H. (1992) General pharmacology of epinastine hydrochloride (WAL 801 CL), an antiallergic agent. Jpn Pharmacol. Ther. 20: 63-90
10. Ohtani, H., Hanada, E., Yamamoto, K., Sawada, Y., Iga, T. (1996a) Pharmacokinetic-pharmacodynamic analysis of the electrocardiographic effects of terfenadine and quinidine in rats. Biol. Pharm. Bull. 19: 1189-1196
11. Ohtani, H., Kotaki, H., Sawada, Y., Iga, T. (1996b) Quantitative determination of epinastine in plasma by high-performance liquid chromatography. J. Chromatogr. B 683: 281-284
12. + channel cloned from human heart. Mol. Pharmacol. 44: 1240-1245
13. Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., Ham, J. (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin. Pharmacol. Ther. 25: 358-371
14. Webb, N. E. (1976) Method for solubilization of selected drug substances. Bull. Parent. Drug Assoc. 30: 180-186
15. Woosley, R. L., Chen, Y., Freiman, J. P., Gillis, R. A. (1993) Mechanism of the cardiotoxic actions of terfenadine. J. Am. Med. Assoc. 269: 1532-1536